Atsushi Masui Selected Research

AD 6048

11/2015

Atypical antipsychotic properties of AD-6048, a primary metabolite of blonanserin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Masui Research Topics

Disease

3	Squamous Cell Carcinoma of Head and Neck 07/2020 - 02/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 02/2014
1	Hypokinesia (Bradykinesia) 11/2015
1	Catalepsy 11/2015
1	Seizures (Absence Seizure) 03/2014
1	Glioma (Gliomas) 03/2014
1	Autosomal Dominant Lateral Temporal Lobe Epilepsy 03/2014

Drug/Important Bio-Agent (IBA)

2	endonuclease GIBA 01/2016 - 02/2014
2	safingol (sphinganine)IBA 01/2016 - 02/2014
1	EnzymesIBA 07/2020
1	CeramidesIBA 07/2020
1	SphingosineIBA 07/2020
1	AD 6048IBA 11/2015
1	Leucine (L-Leucine)FDA Link 03/2014
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 03/2014
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2014

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 07/2020
1	Radiotherapy 07/2020